Stimulus-triggered enhancement of chilling tolerance in zebrafish embryos

PLoS One. 2017 Feb 6;12(2):e0171520. doi: 10.1371/journal.pone.0171520. eCollection 2017.

Abstract

Background: Cryopreservation of zebrafish embryos is still an unsolved problem despite market demand and massive efforts to preserve genetic variation among numerous existing lines. Chilled storage of embryos might be a step towards developing successful cryopreservation, but no methods to date have worked.

Methods: In the present study, we applied a novel strategy to improve the chilling tolerance of zebrafish embryos by introducing a preconditioning hydrostatic pressure treatment to the embryos. In our experiments, 26-somites and Prim-5 stage zebrafish embryos were chilled at 0°C for 24 hours after preconditioning. Embryo survival rate, ability to reach maturation and fertilizing capacity were tested.

Results: Our results indicate that applied preconditioning technology made it possible for the chilled embryos to develop normally until maturity, and to produce healthy offspring as normal, thus passing on their genetic material successfully. Treated embryos had a significantly higher survival and better developmental rate, moreover the treated group had a higher ratio of normal morphology during continued development. While all controls from chilled embryos died by 30 day-post-fertilization, the treated group reached maturity (~90-120 days) and were able to reproduce, resulting in offspring in expected quantity and quality.

Conclusions: Based on our results, we conclude that the preconditioning technology represents a significant improvement in zebrafish embryo chilling tolerance, thus enabling a long-time survival. Furthermore, as embryonic development is arrested during chilled storage this technology also provides a solution to synchronize or delay the development.

MeSH terms

  • Adaptation, Biological*
  • Animals
  • Cell Survival
  • Cold Temperature*
  • Cryopreservation / methods
  • Cryoprotective Agents
  • Embryo, Nonmammalian* / drug effects
  • Fertility
  • Hydrostatic Pressure
  • Zebrafish*

Substances

  • Cryoprotective Agents

Grants and funding

This research was funded by National Research, Development and Innovation Office (KMR_12-1-2012-0436, nkfih.gov.hu), European Cooperation in Science and Technology (9878-3/2016/FEKUT, www.cost.eu) and Hungarian Government (Research Centre of Excellence - 11476-3/2016/FEKUT, www.nemzetikivalosag.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors who received the funding: BF TK KS CB EL ZC GB BU ÁH JC. The research was also funded by the owners of Applied Cell Technology ltd. These funders provided support in the form of salaries for authors (BF, KS, CB, EL, JC), but did not have any role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific roles of these authors are articulated in the authors’ contribution section.